Medicinal product name Vfend
Pharmaceutical form Film-coated tablet
Strength 50 mg 
Information from the MAH on shortages Not notified
Legal status Rx Prescription (Pr.)
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code J02AC03 Antimycotics for systemic use

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N2
(50 mg)
PVC/Al blister    EU/1/02/212/001  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/02/212/001
Date of authorisation Mar 19, 2002
Marketing authorisation holder, country Pfizer Europe MA EEIG, Belgium